Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and wa...
Gespeichert in:
Veröffentlicht in: | FEBS letters 1992-04, Vol.300 (3), p.241-246 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 246 |
---|---|
container_issue | 3 |
container_start_page | 241 |
container_title | FEBS letters |
container_volume | 300 |
creator | Olds, R.J. Lane, D.A. Boisclair, M. Sas, G. Bock, S.C. Thein, S.L. |
description | The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99,
C
TC→
T
TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule. |
doi_str_mv | 10.1016/0014-5793(92)80854-A |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72859516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>001457939280854A</els_id><sourcerecordid>16235275</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</originalsourceid><addsrcrecordid>eNqNUU1v1DAUtBCoLIV_AJJPqBwC_ozjC1JadVuklbjA2fLHC2uUTRY7abX_HqepgBNwsjwzb549g9BrSt5TQusPhFBRSaX5hWbvGtJIUbVP0IY2ildc1M1TtPkleY5e5PydlHtD9Rk6o1LKWpINSu0wxWmfxoOLA76cgz1CnjDH7YDtn9SdTbEA-L5AOEGYPQS8h2OBi7Lr4hCnUyHy3E9x-Ia7MoenPeA8u1x85imOA95pvX2JnnW2z_Dq8TxHX7fXX65uq93nm09X7a7yQqu2Ekq5oGxNGxCCcaJ8qJ0QQTIISilJvOQNWBVU7aQF53jdeUdkgEY58DU_R29X32Maf8zlV-YQs4e-twOMczaKNVJL-m8hrRmXTMkiFKvQpzHnBJ05pniw6WQoMUsnZgncLIEbzcxDJ6YtY28e_Wd3gPB7aC2h8NuVv489nP7L02yvL9lCLLhmD-iy6ONqBCXWuwjJZB9hKE3FBH4yYYx_f-lPHO2wVw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16235275</pqid></control><display><type>article</type><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</creator><creatorcontrib>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</creatorcontrib><description>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99,
C
TC→
T
TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1016/0014-5793(92)80854-A</identifier><identifier>PMID: 1555650</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Amino Acid Sequence ; Antithrombin ; Antithrombin III - chemistry ; Antithrombin III - genetics ; Antithrombin III - isolation & purification ; Base Sequence ; binding ; Carrier Proteins - genetics ; effects on ; Female ; Genetic Variation ; heparin ; Heparin - genetics ; Heparin binding ; Hereditary thrombosis ; Homozygous mutation ; Humans ; identification ; Leucine - genetics ; Molecular Sequence Data ; Mutation ; Phenylalanine - genetics ; variants</subject><ispartof>FEBS letters, 1992-04, Vol.300 (3), p.241-246</ispartof><rights>1992</rights><rights>FEBS Letters 300 (1992) 1873-3468 © 2015 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</citedby><cites>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/001457939280854A$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1555650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olds, R.J.</creatorcontrib><creatorcontrib>Lane, D.A.</creatorcontrib><creatorcontrib>Boisclair, M.</creatorcontrib><creatorcontrib>Sas, G.</creatorcontrib><creatorcontrib>Bock, S.C.</creatorcontrib><creatorcontrib>Thein, S.L.</creatorcontrib><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99,
C
TC→
T
TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</description><subject>Amino Acid Sequence</subject><subject>Antithrombin</subject><subject>Antithrombin III - chemistry</subject><subject>Antithrombin III - genetics</subject><subject>Antithrombin III - isolation & purification</subject><subject>Base Sequence</subject><subject>binding</subject><subject>Carrier Proteins - genetics</subject><subject>effects on</subject><subject>Female</subject><subject>Genetic Variation</subject><subject>heparin</subject><subject>Heparin - genetics</subject><subject>Heparin binding</subject><subject>Hereditary thrombosis</subject><subject>Homozygous mutation</subject><subject>Humans</subject><subject>identification</subject><subject>Leucine - genetics</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Phenylalanine - genetics</subject><subject>variants</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUU1v1DAUtBCoLIV_AJJPqBwC_ozjC1JadVuklbjA2fLHC2uUTRY7abX_HqepgBNwsjwzb549g9BrSt5TQusPhFBRSaX5hWbvGtJIUbVP0IY2ildc1M1TtPkleY5e5PydlHtD9Rk6o1LKWpINSu0wxWmfxoOLA76cgz1CnjDH7YDtn9SdTbEA-L5AOEGYPQS8h2OBi7Lr4hCnUyHy3E9x-Ia7MoenPeA8u1x85imOA95pvX2JnnW2z_Dq8TxHX7fXX65uq93nm09X7a7yQqu2Ekq5oGxNGxCCcaJ8qJ0QQTIISilJvOQNWBVU7aQF53jdeUdkgEY58DU_R29X32Maf8zlV-YQs4e-twOMczaKNVJL-m8hrRmXTMkiFKvQpzHnBJ05pniw6WQoMUsnZgncLIEbzcxDJ6YtY28e_Wd3gPB7aC2h8NuVv489nP7L02yvL9lCLLhmD-iy6ONqBCXWuwjJZB9hKE3FBH4yYYx_f-lPHO2wVw</recordid><startdate>19920406</startdate><enddate>19920406</enddate><creator>Olds, R.J.</creator><creator>Lane, D.A.</creator><creator>Boisclair, M.</creator><creator>Sas, G.</creator><creator>Bock, S.C.</creator><creator>Thein, S.L.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19920406</creationdate><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><author>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Amino Acid Sequence</topic><topic>Antithrombin</topic><topic>Antithrombin III - chemistry</topic><topic>Antithrombin III - genetics</topic><topic>Antithrombin III - isolation & purification</topic><topic>Base Sequence</topic><topic>binding</topic><topic>Carrier Proteins - genetics</topic><topic>effects on</topic><topic>Female</topic><topic>Genetic Variation</topic><topic>heparin</topic><topic>Heparin - genetics</topic><topic>Heparin binding</topic><topic>Hereditary thrombosis</topic><topic>Homozygous mutation</topic><topic>Humans</topic><topic>identification</topic><topic>Leucine - genetics</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Phenylalanine - genetics</topic><topic>variants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olds, R.J.</creatorcontrib><creatorcontrib>Lane, D.A.</creatorcontrib><creatorcontrib>Boisclair, M.</creatorcontrib><creatorcontrib>Sas, G.</creatorcontrib><creatorcontrib>Bock, S.C.</creatorcontrib><creatorcontrib>Thein, S.L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olds, R.J.</au><au>Lane, D.A.</au><au>Boisclair, M.</au><au>Sas, G.</au><au>Bock, S.C.</au><au>Thein, S.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>1992-04-06</date><risdate>1992</risdate><volume>300</volume><issue>3</issue><spage>241</spage><epage>246</epage><pages>241-246</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99,
C
TC→
T
TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>1555650</pmid><doi>10.1016/0014-5793(92)80854-A</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-5793 |
ispartof | FEBS letters, 1992-04, Vol.300 (3), p.241-246 |
issn | 0014-5793 1873-3468 |
language | eng |
recordid | cdi_proquest_miscellaneous_72859516 |
source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Amino Acid Sequence Antithrombin Antithrombin III - chemistry Antithrombin III - genetics Antithrombin III - isolation & purification Base Sequence binding Carrier Proteins - genetics effects on Female Genetic Variation heparin Heparin - genetics Heparin binding Hereditary thrombosis Homozygous mutation Humans identification Leucine - genetics Molecular Sequence Data Mutation Phenylalanine - genetics variants |
title | Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A32%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antithrombin%20Budapest%203%20An%20antithrombin%20variant%20with%20reduced%20heparin%20affinity%20resulting%20from%20the%20substitution%20L99F&rft.jtitle=FEBS%20letters&rft.au=Olds,%20R.J.&rft.date=1992-04-06&rft.volume=300&rft.issue=3&rft.spage=241&rft.epage=246&rft.pages=241-246&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1016/0014-5793(92)80854-A&rft_dat=%3Cproquest_cross%3E16235275%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16235275&rft_id=info:pmid/1555650&rft_els_id=001457939280854A&rfr_iscdi=true |